HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Top Cited Papers
- 21 June 2009
- journal article
- clinical trial
- Published by Springer Nature in Nature Medicine
- Vol. 15 (8) , 893-900
- https://doi.org/10.1038/nm.1972
Abstract
Highly active antiretroviral therapy is unable to eliminate HIV infection, because the virus persists in latently infected CD4+ T cells—a so-called virus reservoir. Rafick-Pierre Sekaly and his colleagues have shown that central memory CD4+ T cells and transitional memory CD4+ T cells are the main cellular reservoirs for HIV, and they suggest a mechanism that ensures the stability of this reservoir of virus. HIV persists in a reservoir of latently infected CD4+ T cells in individuals treated with highly active antiretroviral therapy (HAART). Here we identify central memory (TCM) and transitional memory (TTM) CD4+ T cells as the major cellular reservoirs for HIV and find that viral persistence is ensured by two different mechanisms. HIV primarily persists in TCM cells in subjects showing reconstitution of the CD4+ compartment upon HAART. This reservoir is maintained through T cell survival and low-level antigen-driven proliferation and is slowly depleted with time. In contrast, proviral DNA is preferentially detected in TTM cells from aviremic individuals with low CD4+ counts and higher amounts of interleukin-7–mediated homeostatic proliferation, a mechanism that ensures the persistence of these cells. Our results suggest that viral eradication might be achieved through the combined use of strategic interventions targeting viral replication and, as in cancer, drugs that interfere with the self renewal and persistence of proliferating memory T cells.Keywords
This publication has 56 references indexed in Scilit:
- HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cellsProceedings of the National Academy of Sciences, 2008
- HIV rebounds from latently infected cells, rather than from continuing low-level replicationProceedings of the National Academy of Sciences, 2008
- Activation drives PD‐1 expression during vaccine‐specific proliferation and following lentiviral infection in macaquesEuropean Journal of Immunology, 2008
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2008
- Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Rα on central and effector memory CD4+ and CD8+ T cell subsetsClinical and Experimental Immunology, 2008
- Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferationThe Journal of Experimental Medicine, 2007
- Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cellsThe Journal of Experimental Medicine, 2006
- Interleukin 7 Regulates the Survival and Generation of Memory CD4 CellsThe Journal of Experimental Medicine, 2003
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997